Drug intelligence / Profile preview

Yiqi Jianpi Shexue Granules

Development stage
Unknown
Lead developer
Kangrentang
Administration
Oral
01

Overview

Yiqi Jianpi Shexue Granules is a traditional Chinese medicine (TCM) formulation used primarily for the treatment of chronic immune thrombocytopenic purpura (ITP) and other conditions characterized by "spleen qi deficiency" and impaired blood control according to TCM theory. The granule is based on classical formulas such as Guipi Tang and Sijunzi Tang, with modifications. Its main ingredients typically include Astragalus membranaceus (Huangqi), Codonopsis pilosula (Dangshen), Poria cocos (Fuling), Atractylodes macrocephala (Baizhu), Glycyrrhiza uralensis (Zhigancao), Eclipta prostrata (Ejiao), Rubia cordifolia (Qiancao) among others[3][4]. The mechanism of action is believed to involve tonifying spleen qi, nourishing blood, promoting hemostasis by improving platelet count and function, modulating immune response, and reducing bleeding symptoms in ITP patients[1][2][8]. Clinical studies suggest it can improve symptoms of fatigue, dizziness, spontaneous bruising/bleeding associated with ITP or similar syndromes in TCM[1][4][8].

Brand names
Yiqi Jianpi Shexue Granules益气健脾摄血颗粒健脾益气摄血颗粒
Other names
Jianpi Yiqi Shexue Granules健脾益气摄血颗粒

Beyond the preview

Go deeper on Yiqi Jianpi Shexue Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yiqi Jianpi Shexue Granules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call